41 Results | PPARδ | Search

Product TypeClear Filters

Analytical Chemistry (5)

Environmental Toxicology (1)

Lipids (2)

Natural Products (1)

Small Molecule Modulators (41)

Receptor Pharmacology (41)

Agonists (41)

Small Molecule Activators (2)

Small Molecule Inhibitors (6)

Research AreaClear Filters

Cancer (4)

Cardiovascular System (17)

Cell Biology (7)

Endocrinology & Metabolism (38)

Epigenetics, Transcription, & Translation (1)

Immunology & Inflammation (10)

Lipid Biochemistry (12)

Oxidative Stress & Reactive Species (2)

ApplicationClear Filters

Mass Spectrometry (5)

Displaying 1 - 25 of 41 Results

GW 0742

A selective agonist of PPARδ

CAS No. 317318-84-6

Item No. 10006798

Formulation: A crystalline solid

Purity: ≥95%

GW 610742

5 mg

$90

Add

10 mg

$168

Add

25 mg

$392

Add

50 mg

$609

Add

MBX-8025 (sodium salt)

A PPARδ agonist

Item No. 28761

Formulation: A crystalline solid

Purity: ≥95%

Seladelpar

1 mg

$40

Add

5 mg

$124

Add

10 mg

$228

Add

25 mg

$469

Add

MA-0204

An agonist of PPARδ

CAS No. 2095128-17-7

Item No. 26025

Formulation: A solid

Purity: ≥95%

1 mg

$193

Add

5 mg

$482

Add

10 mg

$770

Add

CAY10592

A selective partial PPARδ agonist

CAS No. 685139-10-0

Item No. 10012536

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$40

Add

5 mg

$171

Add

10 mg

$302

Add

GW 501516

A selective PPARδ-agonist with anti-obesity activity

CAS No. 317318-70-0

Item No. 10004272

Formulation: A crystalline solid

Purity: ≥98%

GW 1516

1 mg

$49

Add

5 mg

$96

Add

10 mg

$167

Add

Elafibranor

An agonist of PPARα and PPARδ

CAS No. 923978-27-2

Item No. 23508

Formulation: A solid

Purity: ≥98%

GFT505

1 mg

$36

Add

5 mg

$128

Add

10 mg

$203

Add

ZLY032

A dual FFAR1 and PPARδ agonist

CAS No. 2314465-67-1

Item No. 31485

Formulation: A solid

Purity: ≥98%

5 mg

$49

Add

10 mg

$93

Add

25 mg

$213

Add

50 mg

$400

Add

CAY10771

A dual agonist of FXR and PPARδ

CAS No. 2522599-79-5

Item No. 31758

Formulation: A 5 mg/ml solution in acetonitrile

Purity: ≥98%

1 mg

$107

Add

5 mg

$477

Add

10 mg

$845

Add

HWL-088

An agonist of FFAR1/GPR40 and PPARδ

CAS No. 2378617-96-8

Item No. 30227

Formulation: A solid

Purity: ≥98%

500 µg

$54

Add

1 mg

$257

Add

5 mg

$486

Add

Fenofibric Acid

An agonist of PPARα, PPARγ, and PPARδ and an active metabolite of fenofibrate

CAS No. 42017-89-0

Item No. 19262

Formulation: A crystalline solid

Purity: ≥98%

FNF Acid
NSC 281318
Procetofenic Acid

500 mg

$36

Add

1 g

$68

Add

5 g

$236

Add

10 g

$436

Add

CAY10573

A PPAR pan-agonist

CAS No. 853652-40-1

Item No. 10008846

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$49

Add

1 mg

$93

Add

5 mg

$376

Add

10 mg

$655

Add

GQ-16

A PPARγ partial agonist

CAS No. 870554-67-9

Item No. 11908

Formulation: A crystalline solid

Purity: ≥95%

5 mg

$36

Add

10 mg

$68

Add

50 mg

$268

Add

100 mg

$469

Add

MD001

A dual agonist of PPARα and PPARγ

CAS No. 2254605-76-8

Item No. 27443

Formulation: A crystalline solid

Purity: ≥90%

1 mg

$75

Add

5 mg

$295

Add

10 mg

$479

Add

Amorfrutin B

A PPARγ agonist

CAS No. 78916-42-4

Item No. 19618

Formulation: A solid

Purity: ≥97%

500 µg

$163

Add

1 mg

$278

Add

Troglitazone

Selective PPARγ agonist

CAS No. 97322-87-7

Item No. 71750

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$66

Add

10 mg

$121

Add

50 mg

$503

Add

100 mg

$879

Add

Rosiglitazone

A PPARγ agonist

CAS No. 122320-73-4

Item No. 71740

Formulation: A crystalline solid

Purity: ≥98%

BRL 49653

10 mg

$39

Add

25 mg

$82

Add

50 mg

$136

Add

100 mg

$231

Add

GW 590735

A potent and selective agonist of PPARα

CAS No. 343321-96-0

Item No. 10009880

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$61

Add

5 mg

$260

Add

10 mg

$462

Add

25 mg

$1,006

Add

Rosiglitazone (potassium salt)

A PPARγ agonist

CAS No. 316371-84-3

Item No. 71742

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$36

Add

10 mg

$68

Add

50 mg

$268

Add

100 mg

$469

Add

9(10)-Nitrooleate

A mixture of 9-nitrooleate and 10-nitrooleate

CAS No. 1092676-99-7

Item No. 33896

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥95% (1:1 mixture of isomers)

9(10)-Nitrooleic Acid
OA-NO₂
9(10)-nitro-9-trans-Octadecenoic Acid

100 µg

$55

Add

500 µg

$165

Add

1 mg

$275

Add

Bezafibrate

A non-selective PPAR agonist

CAS No. 41859-67-0

Item No. 10009145

Formulation: A crystalline solid

Purity: ≥98%

Benzofibrate
BM 15075

1 g

$28

Add

5 g

$90

Add

10 g

$165

Add

25 g

$275

Add

GW 7647

A selective PPARα agonist

CAS No. 265129-71-3

Item No. 10008613

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$41

Add

10 mg

$235

Add

25 mg

$437

Add

GW 9578

A potent, selective PPARα agonist

CAS No. 247923-29-1

Item No. 10011211

Formulation: A 10 mg/ml solution in methyl acetate

Purity: ≥98%

500 µg

$33

Add

1 mg

$62

Add

5 mg

$248

Add

10 mg

$432

Add

AUDA

A potent inhibitor of soluble epoxide hydrolase

CAS No. 479413-70-2

Item No. 10007927

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$35

Add

10 mg

$54

Add

50 mg

$253

Add

100 mg

$472

Add

Muraglitazar

A PPARα and PPARγ dual agonist

CAS No. 331741-94-7

Item No. 10007853

Formulation: A crystalline powder

Purity: ≥90%

BMS-298585

1 mg

$376

Add

Troglitazone-d₄

An internal standard for the quantification of troglitazone

CAS No. 2749370-85-0

Item No. 28908

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₄)

1 mg

$436

Add

Displaying 1 - 25 of 41 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A 5 mg/ml solution in acetonitrile

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥90%

Formulation: A solid

Purity: ≥97%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥95% (1:1 mixture of isomers)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A 10 mg/ml solution in methyl acetate

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline powder

Purity: ≥90%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d4)

Purity: ≥99% deuterated forms (d₁-d₄)